Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-29

FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma Holdings, Inc.'s supplemental application for Rizatriptan Benzoate, enabling the marketing of a generic rizatriptan benzoate prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)